Analyst firms · Guggenheim · ALMS
Guggenheim ALMS price target and rating history
Alumis Inc. (ALMS) · Health Care
Guggenheim rates Alumis Inc. (ALMS) Neutral with a $18 price target, as of its latest action on Sep 3, 2026. It has published 3 rating actions on ALMS since July 2024, including 0 upgrades and 1 downgrade. Across 4 firms with a ALMS price target in the last 12 months, the median target is $40.50.
- Current rating
- Neutral
- Price target
- $18
- Median target, all firms
- $40.50
- Actions on ALMS
- 3
Guggenheim price target on ALMS
Every Guggenheim rating on ALMS
- Sep 3, 2026
- Jun 10, 2025
- Jul 23, 2024
How other firms rate ALMS
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Guggenheim | Neutral | Sep 3, 2026 | |
| H.C. Wainwright | Buy | $15 | Sep 2, 2026 |
| Raymond James | Strong Buy | $46 | Mar 11, 2026 |
| Stifel | Buy | $44 | Feb 25, 2026 |
| Chardan Capital Markets | Buy | $37 | Jan 21, 2026 |
Questions about Guggenheim and ALMS
- What is Guggenheim's price target for ALMS?
- Guggenheim's latest stated price target for Alumis Inc. (ALMS) is $18, from its action on Jun 10, 2025.
- What is Guggenheim's rating on ALMS?
- Guggenheim rates ALMS Neutral, a neutral rating, as of Sep 3, 2026.
- When did Guggenheim last change its view on ALMS?
- On Sep 3, 2026, Guggenheim downgrades to Neutral from Buy.
- How does Guggenheim's ALMS target compare with other analysts?
- Across 4 firms with a ALMS price target in the last 12 months, the median target is $40.50.
More ALMS rating histories
All Guggenheim ratingsALMS news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.